Top news of the week: 14.04.2020.

#CoronaVirus #COVID19 #pharmaceuticals #biotechnology #CoronaOutbreak #CoronaPandemic #biospace #lifesciences #Biopharma #digitization

Companies And Industries

On Apr 13, 2020
@IAmBiotech shared
#Biopharma Update on the Novel #Coronavirus #COVID19 https://t.co/pSgEym0n3y https://t.co/0FE4XDKH39
Open

Biopharma Update on the Novel Coronavirus: April 10

Biopharma Update on the Novel Coronavirus: April 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.

On Apr 7, 2020
@BioWorld shared
Biopharma deals and M&As down slightly, but respectable showing despite pandemic https://t.co/JpPsXHqzW0
Open

Biopharma deals and M&As down slightly, but respectable showing despite pandemic

Biopharma deals and M&As down slightly, but respectable showing despite pandemic

With nearly a quarter of the activity announced in March focused on COVID-19, the first quarter of 2020 appears to be on target to beat the deal and M&A values of two of the last three ...

On Apr 10, 2020
@CellCultureDish shared
🔬 Weekly Biotechnology News Wrap-Up - 04/10/2020  - https://t.co/hRnY3AygBe
Open

The Dish’s Weekly Biotechnology News Wrap Up – April 10, 2020

The Dish’s Weekly Biotechnology News Wrap Up – April 10, 2020

*|RSSFEED:DATE|* Incase you missed it. We summarize the week's top biotechnology stories.

On Apr 9, 2020
@Labiotech_eu shared
Investors must be ready for the #digitization of #biotech. What do you think? 🧐Read the full article by subscribing to Labiotech Insider 30 days for free: 👉🏻 https://t.co/FcJ0AM3Iwx 👈🏻#venturecapital #investment #startup #interview #LBRefresh #membership https://t.co/Uou1rT9Azk
Open

Investors Must Be Ready for the Digitization of Biotech

Investors Must Be Ready for the Digitization of Biotech

For a few decades, the worlds of biotech and digital technology have been on separate paths. Franck Lescure, Partner at the French VC firm Elaia Partners, explains how the two fields are ...

On Apr 9, 2020
@Biotechnology shared
Biotech Beach Emergent BioSolutions Aims to Fight COVID-19 https://t.co/245iy7awij https://t.co/CnFsbM42M5
Open

Biotech Beach Emergent BioSolutions Aims to Fight COVID-19

Biotech Beach Emergent BioSolutions Aims to Fight COVID-19

Biopharma companies are attacking the COVID-19 pandemic from many fronts. Emergent BioSolutions is among those leading the fight.

On Apr 7, 2020
@matthewherper shared
RT @DanBudwick: [email protected] partner Abbie Celniker & @EQRxINC founder Alexis Borisy catch up w/ @statnews on life in biotech amidst the COVID-19 pandemic https://t.co/IGH1WU5o0c
Open

Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’

Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’

In this edition: Will #JPM21 be a thing? Also, some straight talk from Alexis Borisy, Daphne Zohar and Abbie Celniker, and another biotech investor survey.

On Apr 7, 2020
@Biotechnology shared
Martin Shkreli Pleads for 3-Month Prison Furlough to Help COVID-19 R&D Efforts https://t.co/pJxKNUTMtU https://t.co/oFFbVE2OTi
Open

Martin Shkreli Pleads for 3-Month Prison Furlough to Help COVID-19 R&D Efforts

Martin Shkreli Pleads for 3-Month Prison Furlough to Help COVID-19 R&D Efforts

Disgraced pharma executive Martin Shkreli is pleading to be temporarily let out of prison in order to join in the fight against COVID-19, the disease that has swept across the globe ...

On Apr 13, 2020
@matthewherper shared
RT @adamfeuerstein: Biotech in the time of coronavirus: The return of mergers, acquisitions, and deals https://t.co/IMQ6jAdYTo Also, did $SAGE 's CEO take a paycut? American First and $GILD, plus more...
Open

Biotech in the time of coronavirus: The return of mergers, acquisitions, and deals

Biotech in the time of coronavirus: The return of mergers, acquisitions, and deals

In this week's column: When will biotech M&A return? Did Sage Therapeutics CEO take a pay cut? And biotech in an America First world.